Intellectual Property Damages,
Valuation & Expert Testimony

Independent financial and economic analysis for

patent, trademark, copyright, trade secret,

and licensing matters.

Gleason IP helps attorneys, corporations,

and innovators quantify damages, value intellectual

property assets, assess litigation exposure,

and support critical business decisions.

Patent Damages IP Valuation Licensing & Royalties Expert Testimony

Speak With an IP Expert

Independent support for:

✓ Patent Damages
✓ IP Valuation
✓ Licensing & Royalties
✓ Expert Testimony

412.391.9010

Schedule a Consultation

Featured
Insight

Supreme Court Narrows Active
Inducement Claims in Vascepa Generic Drug Decision

The Supreme Court’s recent decision provides

important guidance regarding induced infringement,

skinny-label carve outs, and litigation strategy

for branded and generic pharmaceutical companies.

Read Analysis →

Meet Our Intellectual Property Experts

Our intellectual property professionals assist law firms, corporations, and innovators with IP valuation, damages analysis, licensing matters, expert testimony, and strategic financial analysis. Our team combines deep technical expertise with decades of experience supporting complex intellectual property disputes and business decisions.

LATEST INSIGHTS

Recent analysis, commentary, and developments impacting intellectual property

disputes, valuation, damages, and licensing matters.

Supreme Court Narrows Active Inducement Claims in Vascepa Generic Drug Decision

The Supreme Court’s unanimous Hikma v. Amarin decision clarifies the level of affirmative conduct required to support active-inducement claims involving pharmaceutical skinny labels.

Gleason IP News & Updates

Delaware Chief Judge Connolly Credits Ivan Hofmann’s Commercial Success Testimony in a Pharmaceutical Patent Case Gleason IP was retained by multiple defendants in a patent infringement matter related to Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.’s Lonsurf® (trifluridine and tipiracil) tablets. Lonsurf® tablets are a prescription medicine for stomach cancer (sometimes referred to […]

Patent-Thickets in the News

Recently the practice of establishing so called patent-thickets for biologic products has been questioned as a potentially abusive way of preventing biosimilar competition. In June 2020, the Honorable Judge Manish S. Shah in the United States District Court for the Northern District of Illinois Eastern Division issued a Memorandum Opinion and Order dismissing a class […]

View All Intellectual Property Insights →

Need an Intellectual Property Expert?

Whether evaluating patent damages, valuing intellectual

property assets, assessing licensing economics, or

preparing expert testimony, our professionals can help.